| Routine Health Screening Market (HLC299A) |
| Cytology, ThinPrep Pap Test |
|
FDA-approved test for routine cervical cancer screening at 3-year intervals in individuals ≥21 years old with a cervix. For those aged 25-65, Human Papillomavirus (HPV) High-Risk Screen by Transcription-Mediated Amplification (TMA) with Reflex to Genotypes 16 and 18/45, ThinPrep, is preferred. |
| HPV Primary Screen by PCR With Reflex to Cytology |
|
This test amplifies DNA of HPV16, HPV18, and 12 other high-risk HPV types (31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68) associated with cervical cancer and its precursor lesions. |
| Aluminum, Serum |
|
The preferred test for routine aluminum screening, particularly useful in assessing aluminum toxicity related to dialysis, is aluminum urine testing, especially for chronic exposure. |
|
